EZH2 and neoplasm: Next, we extracted a list of the most significantly deregulated ERG/EZH2 targets between the two tumor subgroups (ERG fusion positive vs ERG fusion negative tumors) in the Sboner dataset24 (Supplementary Fig. 9).